Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00019643 · ClinicalTrials.gov registry record
Factors Affecting Weight Gain in Women Receiving Adjuvant Chemotherapy for Breast Cancer
A clinical trial, sponsored by National Institutes of Health Clinical Center (CC).
- Terminated
- Registry status
- 26
- Enrollment target
NCT00019643 is a clinical trial that was terminated before completion, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 26 participants.
The verdict
NCT00019643 was terminated before completion, sponsored by National Institutes of Health Clinical Center (CC).
- TERMINATED
- Registry status
- 26 participants
- Enrollment target
Study Summary
RATIONALE: Chemotherapy may affect various factors that can lead to weight gain. PURPOSE: Clinical trial to evaluate factors that may affect weight gain in women receiving adjuvant chemotherapy for stage I, stage II, or stage IIIA breast cancer.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 1999-08 |
| Est. Completion | 2007-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00019643
The ClinicalTrials.gov registry entry for NCT00019643 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institutes of Health Clinical Center (CC), which has 338 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00019643 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00019643 about?
NCT00019643 is a clinical study titled "Factors Affecting Weight Gain in Women Receiving Adjuvant Chemotherapy for Breast Cancer". RATIONALE: Chemotherapy may affect various factors that can lead to weight gain. PURPOSE: Clinical trial to evaluate factors that may affect weight gain in women receiving adjuvant chemotherapy for stage I, stage II, or stage IIIA breast cancer.
What is the current status of trial NCT00019643?
This trial is currently terminated. The enrollment target is 26 participants. The study started on 1999-08. Estimated completion is 2007-04.
Who is sponsoring clinical trial NCT00019643?
This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.